Dna changes linked to cervical cancer risk
Part of Cancer, Infections, Women’s health & pregnancy clinical trials.
This study looks at how changes in DNA (called methylation) may be linked to a higher chance of developing cervical cancer. By studying blood and tissue samples from people with abnormal screening results, researchers hope to find better ways to predict risk and detect cervical cancer earlier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old and have a history of sexual activity
- You have had an HPV test and a Pap (TCT) test done at the same time at a gynecology clinic
- If your HPV or Pap test results are abnormal, you are willing to have a tissue biopsy to check further
- You are not pregnant or breastfeeding
- You do not have immune disorders like AIDS or lupus, and have not had an organ transplant
- You have not used vaginal douches, probiotics, antibiotics, or antifungal treatments within the specified time before sample collection
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to screen for cervical cancer by looking for certain DNA changes in a swab sample from the cervix. It may help find cancer or pre-cancer earlier, when it is easier to treat.
This study tests a new questionnaire that may help doctors better identify which women need treatment for cervical changes. It is for women who have had an abnormal Pap smear or a positive HPV test and are going for a colposcopy (a closer look at the cervix).
This study looks at how selenium levels in your tissues relate to HPV-related cervical changes and their outcomes. It aims to understand if selenium affects how these lesions develop or heal.
This study looks for “methylated DNA markers” (special DNA patterns) to help detect endometrial, ovarian, and cervical cancers, and to support doctors around planned procedures. It may help find cancer earlier or better sort out who needs closer treatment.
This trial checks how well cervical cancer responds to surgery, radiation, and chemotherapy by measuring HPV DNA and RNA in blood and cervical mucus. It aims to improve monitoring during treatment.
This study looks at how HPV (the virus that can cause cervical cancer) and the natural balance of bacteria in the vagina affect women who have HIV. It may help doctors understand how to better prevent cervical cancer in women with weakened immune systems.
Hear when a new Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.